Presentation TCT 2025 TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis Presenter: Mehmet Cilingiroglu October 28, 2025